Thursday, May 19, 2022

AIIMS Delhi begins clinical Covaxin trials on children in 12-18 age group

AIIMS Delhi has begun screening for clinical trials of Covaxin, Covid-19 vaccine, on children from today, as per ANI. 

The trial is planned on 525 subjects at various sites, including AIIMS of Delhi and Patna, as well as of Meditrina Institute of Medical Sciences, Nagpur. 

The two doses would be administered at an interval fo 28 days. 

Covaxin will be the first such vaccine in India that would cater to inoculating children. 

AIIMS Patna has already begun trials in the 12-18 age group. After them, it would be trials on 6-12 years and then 2-6 years. 

On May 13, the Drugs Controller General of India (DCGI) had given nod to phase-2/3 trials on children ageing 2-18-year-olds. 


Read More

Delhi Lt Gov Anil Baijal has resigned, say sources

Delhi Lieutenant Governor Anil Baijal has submitted his resignation to President Ram Nath Kovind citing "personal reasons", sources told NDTV on Wednesday. A retired civil...
Support Us
Contribute to see NewsBred grow. And rejoice that your input has made it possible.